Search Results - "Yu, HyunKyung"

Mechanisms of carvacrol-induced expression of type I collagen gene by Lee, Jongsung, Jung, Eunsun, Yu, Hyunkyung, Kim, Yongwoo, Ha, Jaehyoun, Kim, Yeong Shik, Park, Deokhoon

“…Summary Background Skin aging is accompanied by wrinkle formation and appears to be principally related to decreases in the levels of type I collagen, the…”
Get full text

Treatment of experimental human breast cancer and lung cancer brain metastases in mice by macitentan, a dual antagonist of endothelin receptors, combined with paclitaxel by Lee, Ho Jeong, Hanibuchi, Masaki, Kim, Sun-Jin, Yu, Hyunkyung, Kim, Mark Seungwook, He, Junqin, Langley, Robert R, Lehembre, François, Regenass, Urs, Fidler, Isaiah J

“…We recently demonstrated that brain endothelial cells and astrocytes protect cancer cells from chemotherapy through an endothelin-dependent signaling…”
Get full text

Abstract 553: Assessment of CNTN4 expression and its association with PD-L1 across 18 various cancers using an artificial intelligence-powered immunohistochemistry analyzer by Shin, Seunghwan, Moon, Jimin, Cho, Soo Ick, Ock, Chan-Young, Jeon, Bu-Nam, Kim, Gyeongyeon, Yu, Hyunkyung, Cha, Miyoung

“…Background: Contactin-4 (CNTN4) has been identified as an inhibitory immune checkpoint protein and mainly expressed on tumor cells. It interacts with APP…”
Get full text

Abstract 740: CNTN4 as a novel target for solid cancer with antibody-drug conjugate by Cha, Mi Young, Kim, Hyunuk, Byun, Seungmin, Ha, Youngeun, Park, Kitae, Yu, Hyunkyung, Jeon, Bu-Nam, Kim, Mira, Moon, Soojung, Park, Kyung Mi, Park, Hansoo

“…As a novel immune checkpoint, we previously confirmed that contactin 4 (CNTN4) regulates T cell activity negatively by binding to amyloid precursor protein…”
Get full text

Contactin-4 suppresses antitumor T cell responses by engaging amyloid precursor protein by Jeon, Bu-Nam, Kim, Sujeong, Kim, Yunjae, Yu, Hyunkyung, Park, Changho, Kim, Gihyeon, Ha, Youngeun, Kim, Gyeong-Yeon, Kim, Hyunuk, Palucka, Karolina A, Lee, Charles, Cha, Miyoung, Park, Hansoo

“…Immune checkpoint inhibitors have substantial advanced tumor treatment, but their limited benefits and strong responses in only a subset of patients remain…”
Get more information

Abstract 804: Antitumor activity of the potent and novel FLT3 inhibitor HM43239 in acute myeloid leukemia by Lee, Miyoung, Ha, Young Eun, Moon, Mi Jin, Byun, Joo-Yun, Yu, HyunKyung, Kang, SeokJong, Lee, JaeHo, Lee, Kyuhang, Kim, Eunkyung, Kim, Eunyoung, Lee, Ho Jeong, Kim, YoungHoon, Ahn, YoungGil, Suh, KweeHyun, Kim, Sun-Jin

“…Introduction: Acute myeloid leukemia (AML) with FMS-like tyrosine kinase 3 (FLT3) mutations is associated with poor prognosis with a high risk of relapse after…”
Get full text

Abstract 1868: Novel immune checkpoint inhibitor: In vivo and in vitro efficacy of anti-CNTN4 antibody, GENA-104A16 in the models with increased CNTN4 expression by Cha, Mi Young, Yu, Hyunkyung, Jeon, Bu-Nam, Ha, Youngeun, Kim, Hyunuk, Kim, Yunyeon, Chung, Joo-Yeon, Kim, Gihyeon, Park, Changho, Park, Kyung Mi, Park, Hansoo

“…We previously suggested that contactin 4 (CNTN4) negatively regulates T cell activity through binding with amyloid precursor protein on T cells. In addition,…”
Get full text

Abstract 2968: Development of anti-APP antibody targeting APP/CNTN4 axis as a novel cancer immunotherapy by Cha, Mi Young, Ha, Youngeun, Jeon, Bu-Nam, Kim, Hyunuk, Kim, Yunyeon, Lee, Jiyeong, Kim, Han-Sol, Jeong, A-Reum, Yu, Hyunkyung, Park, Kyung Mi, Park, Hansoo

“…Immunotherapeutic treatment has profoundly improved the clinical outcomes in patients with advanced cancers. However, most patients still have not responded to…”
Get full text

Abstract 4780: A novel, potent and selective FGFR4 inhibitor, HM81422 in hepatocellular carcinoma with FGFR4-driven pathway activation by Lee, JaeHo, Kang, Hyunjeong, Koo, Kyounghwa, Ha, Youngeun, Lim, Sun Young, Byun, Joo-Yun, Yu, Hyunkyung, Song, Taehun, Lee, Moonsub, Jung, Seung Hyun, Kim, Taewoo, Bang, Hyojeong, Kim, Eunyoung, Kang, Jahoon, Lee, Ho Jeong, Kim, YoungHoon, Ahn, YoungGil, Suh, KweeHyun, Kim, Sun-Jin

“…Introduction: Hepatocellular carcinoma (HCC) is the sixth most prevalent cancer and the second most frequent cause of cancer-related death, however, treatment…”
Get full text

Abstract 1760: The antibody-drug conjugate GENA-111 conjugated to auristatin F shows therapeutic potency in BCAM positive epithelial cancer by Yu, Hyunkyung, Bellocq, Nathalie, Ha, Youngeun, Kim, Hyunuk, Kim, Yunyeon, Jeon, Bu-Nam, Marx, Léo, Pantin, Mathilde, Yoo, Hyunjin, Byun, Seungmin, Chung, Joo-Yeon, Cha, Mi Young, Garrouste, Patrick, Lévy, Frédéric

“…Antibody-drug conjugates (ADCs) are considered as promising cancer treatment modalities that combine the selectivity of antibodies and the cytotoxic properties…”
Get full text

Purification and partial peptide sequence analysis of the boar 32 kDa sperminogen by Yu, H, Yi, L S

“…Boar 32 kDa sperminogen was purified from acid extracts of washed epididymal spermatozoa, and partial peptide sequence was determined. Boar sperminogen was…”
Get more information